Holen Sie sich die Stockscreener-App
3.4419
3.51%
-0.1181
Finanzdaten der Rocket Pharmaceuticals Inc-Aktie (RCKT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
10.50%
71.15
|
64.39 | 69.42 | 73.71 | 67.38 |
| Interest Income/Expense |
0.21%
0.473
|
0.472 | 0.471 | 0.471 | 0.471 |
| Operating Income/Loss |
10.50%
-71.15
|
-64.39 | -69.42 | -73.71 | -67.38 |
| Income/Loss From Continuing Operations Before Tax |
12.37%
-68.92
|
-61.33 | -66.72 | -69.65 | -62.05 |
| Income/Loss From Continuing Operations After Tax |
12.37%
-68.92
|
-61.33 | -66.72 | -69.65 | -62.05 |
|
Net Income/Loss
|
12.37%
-68.92
|
-61.33 | -66.72 | -69.65 | -62.05 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.84%
111.02
|
110.09 | 94.16 | 93.75 | 93.55 |
| Diluted Average Shares |
0.84%
111.02
|
110.09 | 94.16 | 93.75 | 93.55 |
| Basic Earnings Per Share |
10.71%
-0.62
|
-0.56 | -0.71 | -0.74 | -0.66 |
| Diluted Earnings Per Share |
10.71%
-0.62
|
-0.56 | -0.71 | -0.74 | -0.66 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.21%
1.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):